UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055535
Receipt number R000062788
Scientific Title Long-Term Safety Confirmation Trial of a Test Food Product
Date of disclosure of the study information 2024/09/18
Last modified on 2024/09/18 19:18:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Long-Term Safety Confirmation Trial of a Test Food Product

Acronym

Long-Term Safety Confirmation Trial of a Test Food Product

Scientific Title

Long-Term Safety Confirmation Trial of a Test Food Product

Scientific Title:Acronym

Long-Term Safety Confirmation Trial of a Test Food Product

Region

Japan


Condition

Condition

Male/female adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify the safety of long-term consumption (12 weeks) of the test food.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Adverse events and side effects
Changes in clinical laboratory values

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Consumption of the test food (1 capsule a day) for 12 weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

1. Men and women aged 20 to below 65 years at the time of consent acquisition.
2. Subjects who can give informed consent to partake in this study, after being provided with an explanation of the protocol detail.

Key exclusion criteria

1. Subjects who regularly consume Foods for Specified Health Uses (FOSHU), Foods with Functional Claims, or health supplements (including those that may affect sleep, stress, or gut health) three or more times per week and cannot stop consuming them from the time of consent acquisition.
2. Subjects who are taking medications that may affect sleep, stress, or gut health and cannot restrict their use from the time of consent acquisition.
3. Subjects who are participating in the other clinical trials and/or who have participated in the other clinical trials within 4 weeks prior to the current trial and/or who are planning to participate in the other clinical trials.
4. Subjects with excessive alcohol intake.
5. Subjects with previous and/or current medical history of serious diseases in heart, liver, kidney and/or digestive organs.
6. Females who are pregnant or lactating, and females who could become pregnant during trial period.
7. Subjects with allergies to medications and/or food.
8. Subjects who donated blood or component (200 mL) within the last 1 months.
9. Subjects who donated his blood (400 mL) within the last 3 months.
10. Subjects who donated her blood (400 mL) within the last 4 months.
11. Subjects who being collected in total of his blood (1200 mL) within the last 12 months and in this study.
12. Subjects who being collected in total of her blood (800 mL) within the last 12 months and in this study.
13. Subjects deemed unsuitable for participation in the trial by the principal investigator or sub-investigator.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Fumiko
Middle name
Last name Nakamura

Organization

CPCC Company Limited

Division name

Clinical Support Department

Zip code

103-0021

Address

4F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo, Japan

TEL

03-6225-9001

Email

cpcc-contact@cpcc.co.jp


Public contact

Name of contact person

1st name Masanori
Middle name
Last name Numa

Organization

CPCC Company Limited

Division name

Clinical Planning Department

Zip code

103-0021

Address

4F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo, Japan

TEL

03-6225-9001

Homepage URL


Email

cpcc-contact@cpcc.co.jp


Sponsor or person

Institute

CPCC Company Limited

Institute

Department

Personal name



Funding Source

Organization

MEGMILK SNOW BRAND Co.,Ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Chiyoda Paramedical Care Clinic

Address

2F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo 103-0021, Japan

Tel

03-6225-9005

Email

IRB@cpcc.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 09 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 07 Month 29 Day

Date of IRB

2024 Year 07 Month 26 Day

Anticipated trial start date

2024 Year 09 Month 18 Day

Last follow-up date

2025 Year 01 Month 20 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 09 Month 18 Day

Last modified on

2024 Year 09 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062788